NEW YORK (GenomeWeb News) – Genetic Technologies in regulatory documents today said that receipts from customers declined 23 percent year over year during its fiscal second quarter.

For the three months ended Dec. 31, 2012, the Australian company took in A$4.1 million (US$4.3 million) in receipts, down from A$5.3 million in the year-ago period.

Its R&D spending was down 48 percent to A$21,400 from A$41,197 in the year ago period, while advertising and marketing costs were also cut 48 percent to A$217,493 from A$420,274.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.